Sort
50,496 grants matching “lung cancer”
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
$461,991Monte Meier Winslow · Stanford University · R01 · FY2020 · CA
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
$461,991Monte Meier Winslow · Stanford University · R01 · FY2021 · CA
3H-pyrazolo[4,3-f]quinoline-containing compounds as selective and tunable protein kinase inhibitors
$461,983Herman O Sintim · University Of Notre Dame · R01 · FY2025 · CA
TIE2 Activation for the Treatment of Chemical-Induced Acute Lung Injury
$461,955Christopher D Kontos · Duke University · U01 · FY2017 · ES
RRM1/PTEN Axis in Non-Small Cell Lung Cancer
$461,937Gerold Bepler · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2007 · CA
Stress Induction of Glucose Regulated Protein GRP78/BiP
$461,880Amy S Lee · University Of Southern California · R01 · FY2015 · CA
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling
$461,852Michelle Christine Mendoza · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
$461,845Jennifer Rose Klemp · University Of Kansas Medical Center · R01 · FY2023 · CA
Computer aided diagnosis of cancer metastases in the brain
$461,828Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2016 · LM
Discovery of novel cytotoxic natural products from marine sponges and fungi
$461,782Phil Crews · University Of California Santa Cruz · R01 · FY2008 · CA
Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer
$461,779Punita Dhawan · University Of Nebraska Medical Center · R01 · FY2022 · CA
PROTOCOL NWU2013-02-01A PHASE I TRIAL OF INHALED ILOPROST FOR THE PREVENTION OF LUNG CANCER IN FORMER SMOKERS
$461,777Raymond Bergan · Northwestern University At Chicago · N01 · FY2017 · CA
Natural Language Processing Platform for Cancer Surveillance
$461,775Guergana K. Savova · Boston Children'S Hospital · UG3 · FY2019 · CA
Dissemination and implementation of a corrective intervention to improve mediasti
$461,765Raymond U Osarogiagbon · University Of Memphis · R01 · FY2013 · CA
Integrated framework to predict chemotherapy response post lung tumor resection
$461,750Hermann Frieboes · University Of Louisville · R15 · FY2016 · CA
Urokinase-type plasminogen activator (uPA) in pathogenesis of lymphangioleiomyomatosis (LAM)
$461,690Victoria Stepanova · University Of Pennsylvania · R01 · FY2020 · HL
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion
$461,646Xiang Zhang · Baylor College Of Medicine · R01 · FY2024 · CA
Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu
$461,610Hak Soo Choi · Beth Israel Deaconess Medical Center · R01 · FY2013 · EB
Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer
$461,573Chuan Zhou · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
Liquid biopsy of solitary pulmonary nodule with extracellular vesicles
$461,553Yuan Wan · State University Of Ny,Binghamton · R37 · FY2023 · CA
Effects of Low Dose CT Radiation on Lung Tumorigenesis
$461,531Michael Munley · Wake Forest University Health Sciences · R01 · FY2010 · CA
MAINLINE HEALTH CCOP
$461,522Lankenau Institute For Medical Research · U10 · FY2004 · CA
A novel preclinical model of spontaneous metastasis
$461,518Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
avb6-directed molecular imaging and therapy
$461,496Julie L Sutcliffe · University Of California At Davis · R01 · FY2016 · CA
Harnessing beneficial off-target effects of kinase inhibitors in lung cancer
$461,493Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2016 · CA